Interactive 3D segmentation using connected orthogonal contours von de Bruin, P.W., Dercksen, V.J., Post, F.H., Vossepoel, A.M., Streekstra, G.J., Vos, F.M.

Volltext

Effective Techniques to Visualize Filament-Surface Relationships von Kuß, A., Gensel, M., Meyer, B., Dercksen, V. J., Prohaska, S.

Volltext

Automatic alignment of stacks of filament data von Dercksen, V.J., Weber, B., Gunther, D., Oberlaender, M., Prohaska, S., Hege, H.-C.

Volltext

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consort... von van Kampen, R.J.W, Ramaekers, B.L.T, Lobbezoo, D.J.A, de Boer, M, Dercksen, M.W, van den Berkmortel, F, Smilde, T.J, van de Wouw, A.J, Peters, F.P.J, van Riel, J.M.G, Peters, N.A.J.B, Tjan-Heijnen, V.C.G, Joore, M.A

Volltext

In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlan... von Lobbezoo, D.J.A., van Kampen, R.J.W., Voogd, A.C., Dercksen, M.W., van den Berkmortel, F., Smilde, T.J., van de Wouw, A.J., Peters, F.P.J., van Riel, J.M.G.H., Peters, N.A.J.B., de Boer, M., Peer, P.G.M., Tjan-Heijnen, V.C.G.

Volltext

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? von Lobbezoo, D J A, van Kampen, R J W, Voogd, A C, Dercksen, M W, van den Berkmortel, F, Smilde, T J, van de Wouw, A J, Peters, F P J, van Riel, J M G H, Peters, N A J B, de Boer, M, Peer, P G M, Tjan-Heijnen, V C G

Volltext

A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherla... von Knapen, L.M., Geurts, S.M.E., Ibragimova, K.I.E., Croes, S., Vriens, B.E.P.J., van den Berkmortel, F.W.P.J., Dercksen, M.W., van de Wouw, A.J., Pepels, M.J.A.E., de Fallois, A.O.J., Lobbezoo, D.J.A., de Boer, M., Tjan-Heijnen, V.C.G.

Volltext

Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer von Horeweg, Nanda, Nout, Remi A, Jürgenliemk-Schulz, Ina M, Lutgens, Ludy C H W, Jobsen, Jan J, Haverkort, Marie A D, Mens, Jan Willem M, Slot, Annerie, Wortman, Bastiaan G, de Boer, Stephanie M, Stelloo, Ellen, Verhoeven-Adema, Karen W, Putter, Hein, Smit, Vincent T H B M, Bosse, Tjalling, Creutzberg, Carien L

Volltext

The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry von Pouwels, X. G. L. V., Geurts, S. M. E., Ramaekers, B. L. T., Erdkamp, F., Vriens, B. E. P. J., Aaldering, K. N. A., van de Wouw, A. J., Dercksen, M. W., Smilde, T. J., Peters, N. A. J. B., Riel, J. M. van, Pepels, M. J., Heijnen-Mommers, J., Joore, M. A., Tjan-Heijnen, V. C. G., de Boer, M.

Volltext

395P Receptor status heterogeneity during metastatic breast cancer treatment von Geurts, S., Hermans, K., Van den Berkmortel, F., Tol, J., Heijns, J.B., Dercksen, M., Vriens, B.E.P.J., Aaldering, K., Pepels, M., Peters, N., van de Winkel, L., Boon, E., Teeuwen, N., van Kats, M., Tjan-Heijnen, V.

Volltext

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial von van Ommen-Nijhof, A, Konings, I R, van Zeijl, C J J, Uyl-de Groot, C A, van der Noort, V, Jager, A, Sonke, G S

Volltext

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01) von Charehbili, A., van de Ven, S., Smit, V.T.H.B.M., Meershoek-Klein Kranenbarg, E., Hamdy, N.A.T., Putter, H., Heijns, J.B., van Warmerdam, L.J.C., Kessels, L., Dercksen, M., Pepels, M.J., Maartense, E., van Laarhoven, H.W.M., Vriens, B., Wasser, M.N., van Leeuwen-Stok, A.E., Liefers, G.J., van de Velde, C.J.H., Nortier, J.W.R., Kroep, J.R.

Volltext

An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry von Pouwels, Xavier G. L. V., Ramaekers, Bram L. T., Geurts, Sandra M. E., Erdkamp, Frans, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., van de Wouw, Agnes J., Dercksen, M. W., Smilde, Tineke J., Peters, Natascha A. J. B., van Riel, J. M. G. H., Pepels, Manon J., Heijnen-Mommers, Jose, Tjan-Heijnen, Vivianne C. G., de Boer, Maaike, Joore, Manuela A.

Volltext

392P The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer on first-line endocrine therapy with or without a CDK 4/6 inhibitor von Lammers, S., Thurisch, H., Vriens, I.J.H., Meegdes, M., Engelen, S.M.E., Erdkamp, F.L.G., Dercksen, M., Vriens, B., Aaldering, K., Pepels, M., Winkel, L.V.D., Peters, N., Tol, J., Heijns, J.B., van de Wouw, A., Teeuwen, N., Geurts, S., Tjan-Heijnen, V.

Volltext

Undiagnosed Phenylketonuria Can Exist Everywhere: Results From an International Survey von van Wegberg, Annemiek M.J., Trefz, Friedrich, Gizewska, Maria, Ahmed, Sibtain, Chabraoui, Layachi, van Spronsen, Francjan J., Al Mutairi, F., Arnoux, J.B., Ballhausen, D., Baruteau, J., Bernstein, L., Bijarnia-Mahay, S., Bordugo, A., Brodosi, L., Brooks, S., Chew, H.B., Chyz, K., Coker, M., Collingwood, C., Cornejo, V., Cozens, A., Das, A.M., de las Heras Montero, J., Debray, F.G., Dercksen, M., Descartes, M., Eminoglu, F.T., Enns, G.M., Ford, S., Freisinger, P., Grafakou, O., Gramer, G., Gray, S., Groselj, U., Grünert, S.C., Haas, D., Handoom, B., Harte, T.B., Hendriksz, C., Hoi-Yee Wu, T., Jamuar, S.S., Jonsson, J.J., Jovanovic, A., Kern, I., Kilavuz, S., Knerr, I., Korycinska-Chaaban, D., Kreile, M., Kumru, B., Lanpher, B., Lapatto, R., Leao-Teles, E., Leuzzi, V., Longo, N., Lopez-Uriarte, A., Lubout, C.M.A., MacDonald, A., Mitchell, J., Mochel, F., Morris, A., Moura de Souza, C.F., Munoz, T., Oscarson, M., Õunap, K., Paci, S., Pastores, G.M., Pearl, P.L., Pitt, J., Poon, G., Presner, N., Rabaty, A.A., Reinson, K., Reismann, P., Rink, T., Rocha, J.C., Rodrigues, E., Saini, A.G., Sander, J., Schwartz, I.V.D., Sharma, R., Siriwardena, K., Sirrs, S., Sjarif, D.R., Sondheimer, N., Sparkes, R., Specola, N., Stepien, K.M., Szatmari, I., Tchan, M., Valle, M.G., Vela-Amieva, M., Verdaguer, M.L., Vergano, S.A., Vermeersch, P., Wagenmakers, M.A.E.M., Weinhold, N., Wilson, W.G., Zafeiriou, D., Zhang, H., Ziagaki, A.

Volltext

ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies von Morava, Eva, Tiemes, Vera, Thiel, Christian, Seta, Nathalie, de Lonlay, Pascale, de Klerk, Hans, Mulder, Margot, Rubio-Gozalbo, Estela, Visser, Gepke, van Hasselt, Peter, Horovitz, Dafne D. G., de Souza, Carolina Fischinger Moura, Schwartz, Ida V. D., Green, Andrew, Al-Owain, Mohammed, Uziel, Graciella, Sigaudy, Sabine, Chabrol, Brigitte, van Spronsen, Franc-Jan, Steinert, Martin, Komini, Eleni, Wurm, Donald, Bevot, Andrea, Ayadi, Addelkarim, Huijben, Karin, Dercksen, Marli, Witters, Peter, Jaeken, Jaak, Matthijs, Gert, Lefeber, Dirk J., Wevers, Ron A.

Volltext

Abstract PD6-03: Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience von Vriens, IJ, Butalid, EM, Schepers-van der Sterren, EE, van der Poel, MH, Jansen-Engelen, SL, van Riel, A-MM, van de Wouw, YJ, Vriens, BE, van Haaren, ER, Lemaire, BM, Dercksen, WW, Luiten, EJ, de Boer, M, de Die-Smulders, CE, Derhaag, JG, van Golde, RJ, Tjan-Heijnen, VC

Volltext

A real-world study on implementation of bevacizumab in a cohort of HER2-negative metastatic breast cancer patients: A study of the Southeast Netherlands Breast Cancer Consortium von van Kampen, R.J.W., Lobbezoo, D.J.A., de Boer, M., Dercksen, M.W., Voogd, A.C., van den Berkmortel, F., Smilde, T.J., van de Wouw, A.J., Peters, F.P.J., van Riel, J.M.G., Peters, N.A.J.B., Peer, P.G.M., Joore, M.A., Tjan-Heijnen, V.C.G.

Volltext

Erratum to: ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies von Morava, Eva, Tiemes, Vera, Thiel, Christian, Seta, Nathalie, de Lonlay, Pascale, de Klerk, Hans, Mulder, Margot, Rubio-Gozalbo, Estela, Visser, Gepke, van Hasselt, Peter, Horovitz, Dafne D. G., de Souza, Carolina Fischinger Moura, Schwartz, Ida V. D., Green, Andrew, Al-Owain, Mohammed, Uziel, Graciella, Sigaudy, Sabine, Chabrol, Brigitte, van Spronsen, Franc-Jan, Steinert, Martin, Komini, Eleni, Wurm, Donald, Bevot, Andrea, Ayadi, Addelkarim, Huijben, Karin, Dercksen, Marli, Witters, Peter, Jaeken, Jaak, Matthijs, Gert, Lefeber, Dirk J., Wevers, Ron A.

Volltext

An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry von Pouwels, Xavier G. L. V., Ramaekers, Bram L. T., Geurts, Sandra M. E., Erdkamp, Frans, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Wouw, Agnes J. Van De, M. W. Dercksen, Smilde, Tineke J., Peters, Natascha A. J. B., J. M. G. H. Van Riel, Pepels, Manon J., Heijnen-Mommers, Jose, Tjan-Heijnen, Vivianne C. G., Boer, Maaike De, Joore, Manuela A.

Volltext bestellen